Aptamer‐targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7‐positive tumours

OBJECTIVES: Aptamer sgc8c is a short DNA sequence that can target protein tyrosine kinase 7 (PTK7), which was overexpressed on many tumour cells. This study aimed to fabricate a novelty DNA nanostructure drug delivery system target on PTK7‐positive cells—CCRF‐CEM (human T‐cell ALL). METHODS: Aptamer...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cell Prolif
Asıl Yazarlar: Liu, Mengting, Ma, Wenjuan, Li, Qianshun, Zhao, Dan, Shao, Xiaoru, Huang, Qian, Hao, Liying, Lin, Yunfeng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Original Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6430458/
https://ncbi.nlm.nih.gov/pubmed/30311693
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cpr.12511
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller